Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
SBA Communications
SBAC
$18B
| $106M | 0.09% |
356,949
-676,738
| -65% | -$200M |
2017 Q2
12 quarters
|
|
227
Artisan Partners
APAM
$2.39B
| $106M | 0.09% |
3,269,351
-478,700
| -13% | -$13.3M |
2017 Q2
12 quarters
|
|
228
Casella Waste Systems
CWST
$5.35B
| $105M | 0.09% |
2,023,799
-361,300
| -15% | -$17.2M |
2014 Q3
23 quarters
|
|
229
GE Aerospace
GE
$317B
| $104M | 0.09% |
3,045,070
-5,488,446
| -64% | -$185M |
2019 Q1
5 quarters
|
|
|
IPHI
230
DELISTED
INPHI CORPORATION
IPHI
| $104M | 0.09% |
881,934
+382,800
| +77% | +$40.3M |
2019 Q2
4 quarters
|
|
231
Ionis Pharmaceuticals
IONS
$7.2B
| $103M | 0.09% |
1,752,867
+64,456
| +4% | +$3.59M |
2019 Q2
4 quarters
|
|
232
Bio-Techne
TECH
$11.4B
| $103M | 0.09% |
1,560,700
-386,580
| -20% | -$23.2M |
2013 Q2
28 quarters
|
|
233
Bank of America
BAC
$375B
| $103M | 0.09% |
4,324,066
+3,130,574
| +262% | +$74M |
2020 Q1
1 quarter
|
|
234
Brady Corp
BRC
$3.96B
| $103M | 0.09% |
2,193,140
-170,000
| -7% | -$7.82M |
2014 Q3
23 quarters
|
|
235
Dollar Tree
DLTR
$22.3B
| $102M | 0.09% |
1,105,503
+1,084,703
| +5,215% | +$90.5M |
2020 Q1
1 quarter
|
|
|
MZTI
236
The Marzetti Company
MZTI
$2.79B
| $102M | 0.09% |
660,163
+31,900
| +5% | +$4.64M |
2013 Q2
28 quarters
|
|
237
Autodesk
ADSK
$48.8B
| $101M | 0.09% |
423,868
+231,500
| +120% | +$45.5M |
2019 Q4
2 quarters
|
|
238
Frontdoor
FTDR
$5.48B
| $101M | 0.09% |
2,283,118
+115,600
| +5% | +$4.72M |
2019 Q2
4 quarters
|
|
239
WD-40
WDFC
$2.74B
| $101M | 0.09% |
509,523
+147,100
| +41% | +$26.7M |
2013 Q2
28 quarters
|
|
240
Strategic Education
STRA
$1.83B
| $101M | 0.09% |
657,289
+63,097
| +11% | +$9.84M |
2013 Q2
28 quarters
|
|
241
Eli Lilly
LLY
$1.04T
| $101M | 0.09% |
613,947
+399,347
| +186% | +$61.3M |
2020 Q1
1 quarter
|
|
242
JD.com
JD
$36.3B
| $101M | 0.09% |
1,672,900
+1,641,600
| +5,245% | +$83.1M |
2019 Q2
4 quarters
|
|
243
Upbound Group
UPBD
$915M
| $101M | 0.09% |
3,615,224
-571,900
| -14% | -$12.7M |
2019 Q1
5 quarters
|
|
244
Takeda Pharmaceutical
TAK
$59.2B
| $101M | 0.09% |
5,607,700
+1,844,300
| +49% | +$33.1M |
2019 Q2
4 quarters
|
|
245
Portland General Electric
POR
$5.33B
| $100M | 0.09% |
2,400,928
-729,800
| -23% | -$33.4M |
2014 Q2
24 quarters
|
|
|
HUYA
246
Huya Inc
HUYA
$512M
| $100M | 0.09% |
5,373,700
+209,300
| +4% | +$3.49M |
2019 Q2
4 quarters
|
|
247
Murphy USA
MUSA
$9.53B
| $100M | 0.09% |
890,200
+211,300
| +31% | +$23.1M |
2018 Q4
6 quarters
|
|
248
Progress Software
PRGS
$1.56B
| $99.6M | 0.09% |
2,570,190
+171,600
| +7% | +$6.54M |
2014 Q4
22 quarters
|
|
249
FirstService
FSV
$5.6B
| $99.1M | 0.09% |
983,893
-18,900
| -2% | -$1.68M |
2015 Q2
20 quarters
|
|
250
Honda
HMC
$42.1B
| $98.5M | 0.09% |
3,852,198
+560,400
| +17% | +$13.6M |
2013 Q3
27 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.